Diffusion Pharmaceuticals Inc(NASDAQ:DFFN) 
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The c...
Website: http://www.diffusionpharma.com
Founded: 2001
Full Time Employees: 10
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-08-17
P
O 3.00
H 3.00
L 3.00
C 3.00
V 0
10EMA 3.00
20EMA 3.00
60EMA 3.00
120EMA 3.00
250EMA 3.00